In addition, we used ACT-1, the anti-human α4β7 antibody known to efficiently block binding of HIV gp120 to α4β7 [47], to block the interaction between HIV and α4β7 during HIV infection. Here, TRAF3IP2 is linked to HIV infectious disease.